发明授权
- 专利标题: Porcine CTLA-4 for xenograft-specific immunosuppression
- 专利标题(中): 猪CTLA-4用于异种移植物特异性免疫抑制
-
申请号: US13316791申请日: 2011-12-12
-
公开(公告)号: US09090708B2公开(公告)日: 2015-07-28
- 发明人: Robert Ian Lechler , Anthony Dorling
- 申请人: Robert Ian Lechler , Anthony Dorling
- 申请人地址: GB London
- 专利权人: IMPERIAL COLLEGE INNOVATIONS LIMITED
- 当前专利权人: IMPERIAL COLLEGE INNOVATIONS LIMITED
- 当前专利权人地址: GB London
- 代理机构: King & Spalding LLP
- 优先权: GB9809280.2 19980430
- 主分类号: C07K14/70
- IPC分类号: C07K14/70 ; A01K67/02 ; A61K39/00 ; C07K16/28 ; C07K14/705 ; A01K67/027 ; A61K38/00 ; A61K48/00
摘要:
The invention provides methods for inhibiting T-cell mediated rejection of a xenotransplanted organ by blocking the delivery of co-stimulatory signal 2 (the B7/CD28 interaction) prevent the activation of xenoreactive T-cells in the recipient. In a first aspect, co-stimulation is prevented by administration to the organ recipient of a soluble form of CTLA-4 from the xenogeneic donor organism. In a second aspect, co-stimulation is antagonized by expressing a ligand for CTLA-4 on the xenogeneic donor cells. In a third aspect, co-stimulation is prevented by expressing recipient organism MHC class II on the surface of the cells of the xenogeneic donor organ.
公开/授权文献
信息查询